These pills are marketed under the brand name Akrimax Pharmaceuticals. The product contains 21 active white pills and seven non-active, pink pills. Pfizer stated in the product being recalled the number of active pills may be incorrect or out of sequence. This could cause women to get too low a dose of the hormonal ingredients and increase the risk of unintentional pregnancy.
Pfizer advised that women who have used the recalled product should use a “non-hormonal form of birth control immediately.”
Curt Hendrix, M.S., C.C.N., C.N.S.